FI883338A0 - Vattenloesningar av doxorubicinhydroklorid. - Google Patents

Vattenloesningar av doxorubicinhydroklorid.

Info

Publication number
FI883338A0
FI883338A0 FI883338A FI883338A FI883338A0 FI 883338 A0 FI883338 A0 FI 883338A0 FI 883338 A FI883338 A FI 883338A FI 883338 A FI883338 A FI 883338A FI 883338 A0 FI883338 A0 FI 883338A0
Authority
FI
Finland
Prior art keywords
doxorubicin hcl
solutions
douborubicinhydrochlorides
butylhydroquinone
tocopherol
Prior art date
Application number
FI883338A
Other languages
English (en)
Other versions
FI883338A (fi
Inventor
Murray Arthur Kaplan
Robert Kevin Perrone
Joseph Ballard Bogardus
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI883338A0 publication Critical patent/FI883338A0/fi
Publication of FI883338A publication Critical patent/FI883338A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883338A 1987-07-16 1988-07-13 Vattenloesningar av doxorubicinhydroklorid. FI883338A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7419087A 1987-07-16 1987-07-16

Publications (2)

Publication Number Publication Date
FI883338A0 true FI883338A0 (fi) 1988-07-13
FI883338A FI883338A (fi) 1989-01-17

Family

ID=22118217

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883338A FI883338A (fi) 1987-07-16 1988-07-13 Vattenloesningar av doxorubicinhydroklorid.

Country Status (11)

Country Link
EP (1) EP0299527B1 (fi)
JP (1) JPH0655668B2 (fi)
KR (1) KR920004097B1 (fi)
AT (1) ATE74759T1 (fi)
AU (1) AU612379B2 (fi)
DE (1) DE3870064D1 (fi)
DK (1) DK396288A (fi)
ES (1) ES2033379T3 (fi)
FI (1) FI883338A (fi)
GR (1) GR3004383T3 (fi)
PT (1) PT88016B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
JP3236608B2 (ja) * 1990-10-04 2001-12-10 日本化薬株式会社 ブレオマイシン類の安定な水溶液
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
KR100327400B1 (ko) * 1998-04-07 2002-05-09 구자홍 음극선관용편향요크
RU2162699C1 (ru) * 2000-02-14 2001-02-10 Закрытое Акционерное Общество "Нита-Фарм" Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов
JP2002037737A (ja) * 2001-08-02 2002-02-06 Nippon Kayaku Co Ltd ブレオマイシン類の安定な水溶液
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
WO2007075092A1 (en) * 2005-12-29 2007-07-05 Instytut Biochemii I Biofizyki New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191847A (en) * 1978-10-20 1982-05-31 Lilly Co Eli Stabilized pharmaceutical solutions of erythromycin
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
JPH01117894A (ja) 1989-05-10
AU612379B2 (en) 1991-07-11
ES2033379T3 (es) 1993-03-16
KR890001571A (ko) 1989-03-27
PT88016B (pt) 1995-03-01
EP0299527B1 (en) 1992-04-15
KR920004097B1 (ko) 1992-05-25
DK396288D0 (da) 1988-07-15
FI883338A (fi) 1989-01-17
DE3870064D1 (de) 1992-05-21
ATE74759T1 (de) 1992-05-15
EP0299527A1 (en) 1989-01-18
JPH0655668B2 (ja) 1994-07-27
AU1905388A (en) 1989-01-19
GR3004383T3 (fi) 1993-03-31
PT88016A (pt) 1989-06-30
DK396288A (da) 1989-01-17

Similar Documents

Publication Publication Date Title
FI870169A (fi) Stabiliserat tokoferol i fri-flytande partikelform
NO173365C (no) Fremgangsm}te for fremstilling av et i det vesentlige ikke-sviende, vandig, antiinflammatorisk steroidpreparat egnet for intranasal administerering
FI883338A0 (fi) Vattenloesningar av doxorubicinhydroklorid.
ES2052646T3 (es) Solucion no acuosa de hidrocloruro de doxorubicina.
SE8102732L (sv) Biologiskt aktiva blandningar eller kompositioner samt salter av heterocykliska foreningar
JPS51144733A (en) A remedy for hepatic failure
NO894811L (no) Vandig doxorubicinloesning.
JPS51144732A (en) A remedy for hepatic failure
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
ATE87210T1 (de) Doxorubicin-loesungen.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY